Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...

The Delhi High Court on Thursday upheld a single judge's refusal of an interim injunction sought by Swiss pharmaceutical ...

In what is being termed a major victory, Natco Pharma has won a legal battle against Swiss pharma giant Roche, allowing the ...

Swiss pharmaceutical giant F Hoffmann-La Roche AG has approached the Supreme Court against the Delhi High Court's order allowing Natco Pharma to manufacture and sell a generic drug of Risdiplam, ...

The Delhi High Court has dismissed Roche's appeal, allowing Natco to launch a generic version of Risdiplam for spinal ...

F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to ...

AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar ...

As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult ...

Roche has moved the Supreme Court challenging a Delhi HC order that allowed Natco Pharma to manufacture and sell a generic ...

Biogen is slated to release its fiscal third-quarter earnings later this month, and analysts are expecting its earnings to ...

In a closely watched case, Roche suffered a setback as a court said it would permit a generic version of its rare disease ...

The drug belantamab mafodotin – also known as Blenrep – has been approved for use for patients with myeloma, when used ...